As India races towards a vaccine for coronavirus, the government has assured that it will expedite regulatory clearances to ensure it is available as soon as possible. However, all vaccines, including the one for coronavirus, whether domestically manufactured or imported, must comply with the requirements and guidelines specified in the Drugs and Cosmetics Rules, 1945 & New Drugs and Clinical Trials Rules, 2019. Vaccine development is a long process to ensure safety and efficacy through different stages and involves regulatory supervision every step of the way. We take you through this carefully drawn journey of vaccine development from a regulatory standpoint.
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.
Already a premium subscriber? LOGIN NOW
What you get on Business Standard Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- 26 years of website archives.
- Preferential invites to Business Standard events.
Subscribe to Business Standard Premium
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Tue, September 22 2020. 15:43 IST